CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice
Volume 15 Issue 1

How Decentralised and Hybrid Clinical Trials Can Support Subject Recruitment and Retention to Support Clinical Trial Success

Decentralised and hybrid clinical trials are delivering benefits for sponsors in a number of ways – delivering quality data quicker to reduce time to market, achievi...
Continue Reading →
Volume 15 Issue 1

Revolutionising Life Sciences Research and Delivery with a New Approach to Modelling Complexity

In life sciences, the adoption of new standards such as SDTM and ADaM is proving critical for efficient and effective data management and sharing. SDTM provides a ne...
Continue Reading →
Volume 14 issue 3

Why We Recognise HIV Vaccine Awareness Day

May 18th is dedicated to HIV Vaccine Awareness Day. The significance of this recurrence is embedded in the years of research that have been dedicated to finding a re...
Continue Reading →
Volume 14 issue 3

Flexible Manufacturing Environments are Vital for Today’s Potent Oral Dose Forms

Driven by advances in oncology treatments and personalised precision medicine, two trends are converging to increasingly challenge pharma's developers and their exte...
Continue Reading →
Volume 13 Issue 3

The Case for a Distributable CDx Model

The past decade has been an exciting era in healthcare for patients and providers with the increasingly broad adoption of precision medicine in drug development, cli...
Continue Reading →
News

ICR cancer drug NXP800 to enter Phase I trials

An investigational drug called NXP800, discovered at the Cancer Research UK Cancer Therapeutics Unit at London’s Institute of Cancer Research (ICR), is to enter Phas...
Continue Reading →
News

Bioclinica Appoints David Herron as Chief Executive Officer

Bioclinica®, a world-leading provider of specialty clinical trial services, has appointed David Herron as the company’s next Chief Executive Officer, effective Janua...
Continue Reading →
News

Bioclinica Launches Clinical Adjudication Led by Experienced Medical Specialists and Researchers for Enhanced Safety & Efficacy in Clinical Trials

Bioclinica®, the world-leading provider of technology-enabled solutions for clinical research, today announces the launch of Bioclinica Clinical Adjudication, a tran...
Continue Reading →
News

Cardiabase, a Banook Group company, supports the World Health Organization (WHO) in the fight against malaria

Cardiabase, a Banook Group company, the global provider of cardiac safety, central imaging and endpoint adjudication services for clinical trials, today announces th...
Continue Reading →
News

Poor aggregation will see ADC targets fail or face long delays

ADC Biotechnology (ADC Bio)‘s leading experts warn that best in class ADCs are being overlooked due to critical aggregation control problems. CDMOs are unable to dev...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026